Literature DB >> 18693302

Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.

Tourandokht Baluchnejadmojarad1, Mehrdad Roghani, Mohammad Reza Jalali Nadoushan, Maryam Bagheri.   

Abstract

A large body of experimental evidence supports a role for oxidative stress as a mediator of nerve cell death in Parkinson's disease (PD). Phytoestrogens such as genistein have been reported to prevent neuronal degeneration caused by increased oxidative burden, therefore, this study examined whether genistein administration at a high dose would attenuate behavioral and structural abnormalities in an experimental model of PD in rat. For this purpose, unilateral intrastriatal 6-hydroxydopamine (6-OHDA, 12.5 microg/5 microL of saline-ascorbate)-lesioned rats were intraperitoneally pretreated with a single and high dose of genistein (10 mg/kg) 1 h before surgery. Apomorphine-induced rotations and the number of Nissl-stained neurons in the substantia nigra pars compacta (SNC) were counted after 2 weeks. Genistein administration could attenuate the rotational behavior in lesioned rats and protect the neurons of SNC against 6-OHDA toxicity. Genistein administration has a protective effect against 6-OHDA toxicity. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18693302     DOI: 10.1002/ptr.2564

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  12 in total

1.  Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

Authors:  Aurélie de Rus Jacquet; Mitali Arun Tambe; Sin Ying Ma; George P McCabe; Jay Hansford C Vest; Jean-Christophe Rochet
Journal:  J Ethnopharmacol       Date:  2017-01-11       Impact factor: 4.360

Review 2.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

Review 3.  Flavonoid-based therapies in the early management of neurodegenerative diseases.

Authors:  Isha Solanki; Priyanka Parihar; Mohammad Lukman Mansuri; Mordhwaj S Parihar
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

Review 4.  Risks and benefits related to alimentary exposure to xenoestrogens.

Authors:  Ilaria Paterni; Carlotta Granchi; Filippo Minutolo
Journal:  Crit Rev Food Sci Nutr       Date:  2017-11-02       Impact factor: 11.176

5.  The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.

Authors:  Nida Jamali-Raeufy; Zahra Mojarrab; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Javad Fahanik-Babaei; Mina Goudarzi
Journal:  Metab Brain Dis       Date:  2020-02-03       Impact factor: 3.584

6.  Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons.

Authors:  Julie Bournival; Patrik Quessy; Maria-Grazia Martinoli
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 7.  The emerging role of nutrition in Parkinson's disease.

Authors:  Stacey E Seidl; Jose A Santiago; Hope Bilyk; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2014-03-07       Impact factor: 5.750

Review 8.  Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Nutrients       Date:  2018-05-19       Impact factor: 5.717

Review 9.  Nutraceuticals in Parkinson's Disease.

Authors:  Liting Hang; Adeline Henry Basil; Kah-Leong Lim
Journal:  Neuromolecular Med       Date:  2016-05-04       Impact factor: 3.843

Review 10.  A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.

Authors:  Jesús Pérez-Hernández; Víctor Javier Zaldívar-Machorro; David Villanueva-Porras; Elisa Vega-Ávila; Anahí Chavarría
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.